Intrathecal Rituximab in Lymphoid Malignancies Involving Central Nervous System
Clinical trial NCT01596127 · TERMINATED
Trial details
- NCT number
- NCT01596127
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-24
- Primary completion
- 2017-03-23
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.